A multicenter real-world study comparing the clinical equivalence of trastuzumab biosimilar HLX02 and reference trastuzumab in the treatment of HER-2-positive breast cancer.

Deng, Weishang; Hu, Jia; Yang, Sensen; Xie, Zeyu; Li, Mengting; Li, Jinjian; Zhuang, Wenbin; Chen, Jisheng

Deng, Weishang; Hu, Jia; Yang, Sensen; Xie, Zeyu; Li, Mengting; Li, Jinjian; Zhuang, Wenbin; Chen, Jisheng.

Afiliación

Deng W; Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou 510080, Guangdong, China.
Hu J; Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou 510080, Guangdong, China.
Yang S; Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou 510080, Guangdong, China.
Xie Z; Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou 510080, Guangdong, China.
Li M; Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou 510080, Guangdong, China.
Li J; Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou 510080, Guangdong, China.
Zhuang W; The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou 510080, Guangdong, China.
Chen J; Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou 510080, Guangdong, China.

Am J Cancer Res ; 13(7): 3113-3122, 2023.

Article en En | MEDLINE | ID: mdl-37559995

Palabras clave

HLX02; biosimilar; breast cancer; real-world study; trastuzumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google